arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Social Sciences · Sociology and Political Science

Clinical report on protocol B-NHL 2001 for childhood B-non Hodgkin's lymphoma

Yaoping Wang

· Chinese Journal of Evidence-Based Pediatrics

See on the map

Abstract

Objective To analyze the efficacy of protocol B-NHL2001 for B cell non-Hodgkin's lymphoma(B-NHL) and anaplastic large cell lymphoma(ALCL).Methods Depending on the reports from developed country and the results of our former protocol NHL-CCCG-97,the protocol B-NHL 2001 revised the eligibility,grouping criteria,intensity of chemotherapy and time of treatment.Patients were divided into low,middle and high risk groups(R1,R2,R3) based on staging and the level of lactate dehydrogenase(LDH),and given 3,5,and 6 courses of chemotherapy respectively.All the patients from 2001 to June 2007 were enrolled.The software of SPSS 11.0 was used and the event free survival was generated by Kaplan-Meier.Results There were 45 patients in total,35 males and 10 females.The average age was 7.1 years(ranged from 10 months to 15.5 years),medium age was 6.3 years.Two patients were in stage Ⅰ,17 in stageⅡ,18 in stageⅢ and 8 in stageⅣ.The original tumor was found in abdomen for 23 patients,nose-pharynges for 7,periephel lymph-nodes for 7,cutaneous for 1,mediastinum for 1,bone for 2,mumps for 2,chest wall for 1 and extensive infiltration in chest and abdomen for 1.They were pathologically sub-classified as Burkitt's for 14 cases,large B cell for 13,anaplastic large cell for 3 and B-NHL(non-lymphoblastic,no further sub-classification) for 15.Two patients were allocated into low risk group(R1),14 into middle risk group(R2) and 29 into high risk group(R3).Three were ruled off the analysis because of abandoning treatment by parents after 1 course therapy without progressive disease(1 of stage Ⅰ,2 of stage Ⅲ).Forty-one of 45 patients reached complete response(CR) after 2 courses of chemotherapy.Another 3 received second look surgery because of residual disease after 3 courses therapy,2 of them were proved CR(no tumor cells in residual mass) by pathology,1 with alive tumor cells.In total,43 of 45 reached CR(95.5%),one of stage Ⅲ and one of stage Ⅳ never reached CR.To Dec 2007,40 of them kept in CR(88.9%) with 6 to 77 months follow-up,average 26.9 months,medium 19 months.Three cases relapsed at original place,bone marrow and in cranial(2 of stage Ⅲ and 1 of stage Ⅳ) which occurred in 5,6 and 8 months.The estimated 5-year event free survival(EFS)was 88.3%.Conclusions The estimated 5-year event free survival indicated that B-NHL 2001 was reasonable for both B-NHL and ALCL and worth to enroll more patients.

More like this